IOTOD 2021

The 19th annual ‘Improving Outcomes in the Treatment of Opioid Dependence’ (IOTOD) meeting took place as a virtual event on the 26th-27th April 2021 with an on-demand viewing period of 30 days until 27th May.

The 2021 IOTOD faculty led an engaging day meeting, featuring international field experts speaking on multiple and emerging topics, such as: opioid analgesic dependence, opioid substitution therapy, reaching all opioid-dependent patients in the COVID-era, the experience so far with long-acting buprenorphine formulations from the patients perspectives, and optimising best approaches to address viral hepatitis in PWIDs


The IOTOD conference partners with internationally-renowned faculty from a variety of backgrounds and specialities.

The faculty includes experts in treatment challenges faced in the COVID-era, opioid analgesia dependence, optimising virology care and much more

Ms Jennifer Kelly

Advanced Pharmacist Independent Prescriber, National Health Service Alcohol and Drug Recovery Services

Greater Glasgow and Clyde, UK

Dr Steve Brinksman

GP and clinical lead for the Substance Misuse Management Good Practice support network (SMMGP)

Birmingham, UK

Ms Lucy Skea

NHS Grampian

Scotland, UK

Ms Caroline Notman

Glasgow Alcohol & Drug Recovery Service

Greater Glasgow and Clyde, UK

Catriona Matheson

Professor in Substance Use, Stirling University,


Dr Michael Kelleher

Consultant Addictions Psychiatrist

South London and Maudsley NHS Foundation Trust, London, England

Dr Stephan Walcher

Director, Concept Centre for Addiction Medicine

Munich, Germany

Ms Cathryn Kemp

Author of ‘Coming Clean'


Maurice Dematteis

Head of the Department of Addictions, University Hospital of Grenoble

Grenoble, France

John Marsden

Professor of Addiction Psychology, Addictions Department, King’s College London

London, UK

Nicholas Lintzeris

Drug and Alcohol Services, South-East Sydney Local Health District

Sydney, Australia

Duncan Hill

Specialist Pharmacist in Substance Misuse, NHS Lanarkshire (NHSL)

Glasgow, Scotland

Graham Foster

Professor of Hepatology, Queen Mary's University of London & Consultant, Bart's Health NHS Trust

London, UK

Ashley Brown

Consultant Hepatologist, St. Mary’s and Hammersmith Hospitals, and Professor of Practice (Viral Hepatitis), Imperial College London

London, UK


The 2021 IOTOD conference is supported by the following companies:




Accord Healthcare

Molteni Farmaceutici


Manoeuvres in the fog: drug-drug interactions in OST
Practicalities of transitioning between opioid agonist treatments
New horizons for treatment: translating the latest research into clinical practice
Tailoring behavioural interventions: emerging evidence and practical implications
View all webcasts